With Academic Collaborators, GSK To Plug For ‘Electroceuticals’
This article was originally published in Start Up
GlaxoSmithKline will fund nonprofit labs across several biomedical and engineering disciplines and offer a $1 million cash prize to probe the role of neural activity in disease. The goal is to build new devices that treat a range of diseases “in their own electrical language.”
You may also be interested in...
Electroceuticals: Drug-Like Effects, Without The Drugs
Electroceuticals could replace the use of pharmaceuticals in many chronic diseases, offering effective treatments without, perhaps, side effects. Medtechs pioneering these next-gen neuromodulation devices are sparking investor interest.
Canadian Generics Group Launches Cost-Saving Campaign
The CGPA is drawing attention to the cost savings Canadians can benefit from through the use of generic drugs via a PSA-style digital campaign.